DOVATO not checked

ViiV Healthcare · DTG/3TC · DTG/3TC FDC

FollowEvery change as it happens, and a Monday email
Stage
in the US and EU
Next date
Phase 2 trial completes
Trials
3 active
7 in total · 3 in the EU
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
Tested for
HIV Infections (3 trials)
Main trialPhase 3
“The purpose of this study is to provide continued access to the study treatment for participants from previous ViiV Healthcare studies who are still benefiting from it and do not have local access after completing the parent study. This continued access will also allow further collection of safety data. Eligible participants are those who completed a ViiV Healthcare-sponsored or collaborative parent study and are currently experiencing clinical benefit. The Sponsor will periodically review the study to consider other treatment access options.”In the company’s words, NCT07393659 on ClinicalTrials.gov
Other names
DTG/3TC · DTG/3TC FDC

Other drugs for HIV Infections

All 36 drugs for HIV Infections

Coming up3

Changes1

Last 90 days

Trials7

TrialPhaseCompletesWhat it tests
Phase 3Recruiting 14 Sep 2032 A Continued Access Study for Participants Transitioning From ViiV Healthcare-sponsored or ViiV Healthcare-collaborative Parent Studies for HIV Treatment
Phase 2Recruiting 28 Oct 2027 A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
Phase 2Not yet recruiting 10 Jun 2032 A Phase 2b Study Evaluating VH4011499 Capsid Inhibitor Long-Acting Injectable Plus Cabotegravir in Treatment Naïve Adults (CINERGY)
Phase 3Completed 23 Apr 2021 Regimen Switch to Dolutegravir/Lamivudine Fixed Dose Combination From Current Antiretroviral Regimen in HIV-1 Infected and Virologically Suppressed Adults (SALSA)
Phase 3Completed 16 Sep 2025 A Study to Evaluate the Efficacy, Safety, Participant Choice and Preference of an Oral Once-daily Regimen or a Long-acting Injectable Regimen Every Two Months for Treatment of Human Immunodeficiency Virus (HIV-1) in Adults Who Have Not Previously Taken Antiretroviral Therapy
Phase 3Completed 23 Jan 2026 A Study to Evaluate Efficacy, Safety and Tolerability in Antiretroviral Therapy (ART)-Experienced Participants of at Least 50 Years of Age Living With Human Immunodeficiency Virus (HIV) With Virologic Suppression Who Switch to DTG/3TC FDC From BIC/FTC/TAF
Phase 1Completed 23 Jul 2021 A Food-effect Study of the Pediatric Dispersible Tablet Formulations of TRIUMEQ® and DOVATO® in Healthy Adult Participants
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026

Follow DOVATO

Following is part of Solo: you see every change to DOVATO the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in